Bath & Body Works reports Q2 results today against a backdrop of heavy selling pressure and a meaningful build in bearish positioning over the past month.
Short sellers have been adding aggressively. Short interest climbed 29% over the past month to 8.5% of the free float — roughly 17.5 million shares — making it one of the more shorted names in specialty retail. The weekly trend turned sharply higher before a one-day drop of 19% on August 24, likely reflecting short covering or settlement noise ahead of the print rather than a genuine shift in conviction. The borrow market remains entirely relaxed: availability runs at nearly 1,900% of short interest, and the cost to borrow is just 0.41%. There is no squeeze pressure here. On price, the stock shed 8.3% on Tuesday alone, extending a 12% weekly loss and an 11.7% monthly decline to close at $17.58 — hitting levels not far above where a cluster of directors bought stock in November 2025.
Options traders are leaning the other way. The put/call ratio dropped to 0.69, more than two standard deviations below its 20-day mean of 0.76 — the most call-skewed reading in months. That divergence is notable: while short sellers were adding positions through August, options flow was shifting toward calls. The stock's 52-week PCR range runs from 0.45 to 2.67, so a reading of 0.69 sits near the bullish extreme of recent history, suggesting some participants are positioning for an upside surprise.
Analyst opinion split sharply in the days before this print. Citigroup upgraded to Buy on August 18, citing what it sees as an undervalued recovery story, while JP Morgan raised its target to $24 from $22 while staying Neutral — a nod to improving fundamentals without full conviction. Those moves sit against Goldman Sachs downgrading to Sell in early July with a $19 target, arguing the stock's challenges in capturing younger consumers and sustaining margins are more structural than cyclical. The consensus remains Hold, with no buy-side majority, and the mean target of roughly $23–$25 implies 30–40% upside from Tuesday's close — a gap that reflects genuine disagreement rather than alignment. Bulls point to more than 1,900 stores, growing digital penetration, and international expansion as underappreciated levers. Bears focus on weak innovation execution, promotional normalization, and the difficulty of rebuilding relevance with a younger demographic.
Past prints have been violent in both directions. The June 2026 quarter triggered a 7% one-day gain and a 13.5% five-day rally. The prior print in May 2026 produced a 14.8% single-session jump. That history of outsized post-earnings moves — in a stock already down 12% on the week — sets up today's release as a test of whether the recent selloff has front-run bad news or created a setup for another sharp reversal.
See the live data behind this article on ORTEX.
Open BBWI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
